Engrail Therapeutics IPO

Engrail Therapeutics is a pharmaceutical company that aims to develop treatments for neuropsychiatric and neurodevelopmental disorders that have unmet needs, which include anxiety disorder, depression, and post-traumatic stress disorder. The company strives to use precision-targeted therapies that act on specific parts of the nervous system involved in the disease process with the goal of maximizing effectiveness and minimizing side effects. Engrail Therapeutics was founded in 2019 and is headquartered in San Diego, California.

Register for Details

For more details on financing and valuation for Engrail Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Engrail Therapeutics

Forge green plus iconForge green minus icon

What is Engrail Therapeutics's IPO price?

The IPO price for Engrail Therapeutics will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Engrail Therapeutics?

Engrail Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Engrail Therapeutics shares pre-IPO?

If you own Engrail Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Engrail Therapeutics a publicly traded company?

Engrail Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Engrail Therapeutics's funding to date?

Engrail Therapeutics has raised $221MM to date.
Forge green plus iconForge green minus icon

When was Engrail Therapeutics founded?

Engrail Therapeutics was founded in 2019.

Who are Engrail Therapeutics's major investors?

Norwest Venture Partners
Eight Roads Ventures
F-Prime Capital
Red Tree Venture Capital
Pivotal Life Sciences
RiverVest Venture Partners

Engrail Therapeutics Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
3/19/2024 Series B-1 and B-2 $157MM raised $XXX.XX $XXX.XX
8/3/2021 Series A-1A, A-1B, A-1C, A-2A, A-2B and A-2C $32MM raised $XXX.XX $XXX.XX
6/18/2020 Series A $32MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Apr 21, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.